Kuhn & Co Investment Counsel’s Pfizer PFE Stock Holding History

Kuhn & Co Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Buy	15,362 +147	+1%	+$3.85K	0.21%	105
2026 Q1	$427K	Buy	15,215 +415	+3%	+$11K	0.28%	92
2025 Q4	$369K	Buy	14,800 +330	+2%	+$8.32K	0.25%	99
2025 Q3	$369K	Sell	14,470 -330	-2%	-$8.14K	0.29%	93
2025 Q2	$359K	Hold	14,800	–	–	0.27%	101
2025 Q1	$375K	Hold	14,800	–	–	0.32%	95
2024 Q4	$393K	Buy	14,800 +240	+2%	+$6.51K	0.33%	89
2024 Q3	$421K	Hold	14,560	–	–	0.36%	88
2024 Q2	$407K	Buy	14,560 +90	+0.6%	+$2.48K	0.37%	90
2024 Q1	$402K	Buy	+14,470	New	+$402K	0.38%	86

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kuhn & Co Investment Counsel's PFE Position: Q2 2026 in Review

Kuhn & Co Investment Counsel increased its Pfizer (PFE) stake by 0.97% in Q2 2026, buying an estimated $3.85K and bringing the position to 15,362 shares worth $370K. The position accounts for 0.21% of the portfolio, ranked #105.

Kuhn & Co Investment Counsel first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $427K in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kuhn & Co Investment Counsel held 15,362 shares of Pfizer worth $370K as of Q2 2026.
Kuhn & Co Investment Counsel bought 147 Pfizer shares in Q2 2026, an estimated $3.85K.
Pfizer made up 0.21% of Kuhn & Co Investment Counsel's portfolio in Q2 2026, its #105 holding.
Kuhn & Co Investment Counsel first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
Kuhn & Co Investment Counsel's Pfizer position peaked at $427K in Q1 2026.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.